Healthy Extracts Reports Strong Q1 2025 Revenue Growth and Optimistic Outlook

Record Revenue in Q1 2025

Healthy Extracts Inc. reported preliminary results indicating anticipated net revenues exceeding $925,000 for the first quarter of 2025, representing a remarkable increase of over 34% compared to the same period last year. This growth is largely attributed to a significant rise in subscription-based customers and robust sales strategies.

Impact of Subscription Growth

The company saw an increase of 83% in direct-to-consumer subscription users, alongside an 81% rise in customers utilizing Amazon's "Subscribe & Save" program. These subscription models not only enhance recurring revenue but also improve customer retention, signaling a positive shift in customer engagement.

Revised Revenue Forecast

Based on the strong performance in Q1, Healthy Extracts has revised its full-year revenue outlook to more than $4.2 million, up from the prior estimate of $4.0 million. This projection reflects an expected growth rate of over 34% from 2024, driven by new product launches and an expanding market presence.

New Product Innovations

Healthy Extracts is preparing to introduce several new products aimed at addressing specific health needs. These include a heart health formulation catering to the significant market of statin users and a MYNUS sugar blocker designed to reduce the impact of sugar from meals. Additionally, on-the-go gel packs will be available, enhancing convenience for customers.

Strategic Focus for Continued Growth

The company's president, Duke Pitts, emphasized the importance of customer retention, innovative product development, and effective marketing strategies in maintaining competitive advantages within the nutraceutical sector. This approach is expected to yield substantial increases in revenues and profitability as the year progresses.

Key Takeaways

Healthy Extracts expects Q1 2025 net revenue to exceed $925,000, reflecting over 34% growth year-on-year.

The company has revised its 2025 revenue outlook to over $4.2 million, up from $4.0 million.

Subscription-based customer growth rose by 83%, enhancing consistent revenue streams.

Upcoming product launches include innovations targeting heart health and sugar impact reduction.

The company maintains a strategic focus on product development and customer retention to drive future growth.